Pearl River Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Pearl River Capital's RPRX Position: Q3 2024 in Review
Pearl River Capital sold out of Royalty Pharma (RPRX) in Q3 2024, closing a stake of 24,062 shares — an estimated $635K sold.
Pearl River Capital first reported a position in RPRX in Q2 2021 and held it in 11 quarters. The position peaked at $2.38M in Q2 2023. 395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.
- Pearl River Capital reported no remaining Royalty Pharma position as of Q3 2024 after selling out during the quarter.
- Pearl River Capital sold 24,062 Royalty Pharma shares in Q3 2024, an estimated $635K.
- Pearl River Capital first reported a position in Royalty Pharma in Q2 2021 and held it in 11 quarters.
- Pearl River Capital's Royalty Pharma position peaked at $2.38M in Q2 2023.
- 395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.
Based on Pearl River Capital's 13F filing for Q3 2024.